Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PolandBack to Poland

Clinical trials in Pleszew

3 clinical trials in Pleszew, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Pleszew at a glance
3
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Pleszew

Open in trial search

Type 2 diabetes mellitus

Not recruiting

A study comparing weekly insulin icodec and semaglutide with daily insulin degludec and insulin aspart in people with type 2 diabetes not well controlled on premixed insulin

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Aspart
  • Sponsor:Novo Nordisk A/S

Breast cancer+1

Not recruiting

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Breast cancer metastatic

Not recruiting

Study Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Pleszew

What the registry says about research in the country

01 Breast Cancer Research

Ongoing clinical trials focusing on advanced treatment approaches for hormone receptor-positive (HR+) and HER2-negative breast cancer. The research evaluates combination therapies to improve progression-free survival in patients who have experienced disease progression after initial treatment.

  • Hormone Receptor-Positive Breast Cancer
  • Advanced/Metastatic Disease
  • Combination Therapy Assessment

Studies incorporate novel therapeutic combinations with established treatments like fulvestrant to enhance treatment outcomes.

02 Triple-Negative Breast Cancer Studies

Innovative research examining the effectiveness of immunotherapy combinations in treating triple-negative breast cancer (TNBC). These trials evaluate various therapeutic approaches for patients with locally recurrent inoperable or metastatic disease.

  • Immunotherapy Combinations
  • Survival Outcomes
  • Treatment Response Assessment

The research compares different treatment combinations including olaparib and pembrolizumab against standard chemotherapy regimens.

Back to PolandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.